Progenity, a San Diego molecular diagnostics company focused on women’s health, reproductive medicine, and oncology, has raised $125 million in a Series B financing led by New York’s Athyrium Capital Management, an earlier investor. The financing marks one of the biggest life sciences deal involving a San Diego company this year. Proceeds from the financing, […]
institute of molecular diagnostics, LLC
NYS Entity Status
NYS Filing Date
JUNE 17, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY RESERVATION
2014 - INSTITUTE OF MOLECULAR DIAGNOSTICS, LLC
Around the Web
- Progenity Raises $125M to Expand Diagnostics for Women’s Health
By Bruce V. Bigelow - Tuesday Nov 7, 2017
- The Trump Debate Inside Conservative Citadels
By BARI WEISS - Thursday Nov 2, 2017
Will the intellectual establishment bow to Rebekah Mercer and Steve Bannon?
- Worldpay Group, a British Payments Processor, Fields Two Possible Takeover Bids
By CHAD BRAY - Tuesday Jul 4, 2017
The company said that it had been contacted by Vantiv, a rival payments company based in Cincinnati, and by the banking powerhouse JPMorgan Chase.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Can the Diagnostic Process Be Shortened to Minutes?
Friday Jun 9, 2017
New technologies are shortening the diagnostic process.